Alzheimer's Disease Trial, Recruiting NCT06385951 Sponsor: University Hospital, Ghent Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06385951
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Mild Cognitive Impairment (MCI) thought to be caused by Alzheimer's Disease
  • People who have been diagnosed with mild Alzheimer's Dementia
  • People who have MCI but have not been formally diagnosed with dementia
  • Healthy individuals (with no cognitive impairment) who are willing to participate as a comparison group

Who may not be able to join:

  • Healthy control participants who have diabetes (this exclusion applies to the healthy control group only)
  • People who have epilepsy
  • People whose depression scores are very high, specifically above 11 on the Geriatric Depression Scale or above 20 on the Beck Depression Inventory
  • People whose anxiety scores are very high, specifically above 22 on the Beck Anxiety Inventory
  • People who have a significant psychiatric or medical condition (confirm with trial site)
  • People who drink alcohol to excess
  • People whose brain MRI scan shows a moderate to severe level of white matter changes (a type of change seen on brain scans), rated above 2 on the Fazekas scale
  • People whose vision or movement difficulties are severe enough to prevent them from completing the trial's virtual reality task

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paul Boon, PhD, University Hospital, Ghent

Phone: 093326483

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Ghent
Registry
ClinicalTrials.gov
Start date
5 March 2024
Est. completion
1 March 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Spatial navigation abilities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov